Bayer HealthCare announced that the U.S. Food and Drug Administration (FDA) has approved Finacea® (azelaic acid) Foam, 15% for the topical (more…)Read More
Tag: Finacea® (azelaic acid) Foam
- Harpar Grace release the results of new Active Peel System clinical study
- European Beauty Tech Leader RÉDUIT Launches New Personalized Skin Care Innovation in U.S.
- DEXLEVO First in Asia to Win BEST Injectable Award at AMWC, the World’s Largest Congress for Aesthetic Anti-aging
- Old skins cells reprogrammed to regain youthful function
- Lipofilling produces lasting improvements for patients with painful finger osteoarthritis